{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:58:41Z","timestamp":1791111521428,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.mcn.2010.12.005","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T09:46:26Z","timestamp":1294393586000},"page":"563-572","source":"Crossref","is-referenced-by-count":45,"title":["Genetic deletion of regulator of G-protein signaling 4 (RGS4) rescues a subset of fragile X related phenotypes in the FMR1 knockout mouse"],"prefix":"10.1016","volume":"46","author":[{"given":"Laura K.K.","family":"Pacey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cifelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek van","family":"der Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Heximer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2010.12.005_bb0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2010.05.002","article-title":"Early developmental alterations in GABAergic protein expression in fragile X knockout mice","volume":"59","author":"Adusei","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2010.12.005_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pharmthera.2007.09.005","article-title":"R4 RGS proteins: regulation of G-protein signaling and beyond","volume":"116","author":"Bansal","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.mcn.2010.12.005_bb0015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/npp.2008.151","article-title":"Small molecule protein\u2013protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles","volume":"34","author":"Blazer","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mcn.2010.12.005_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(01)00568-2","article-title":"Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome","volume":"107","author":"Brown","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2010.12.005_bb0030","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biopsych.2007.09.008","article-title":"Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome","volume":"63","author":"Centonze","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mcn.2010.12.005_bb0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/070674370905401002","article-title":"Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry","volume":"54","author":"Cherkasova","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.mcn.2010.12.005_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/schbul\/sbm042","article-title":"Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia","volume":"34","author":"Chowdari","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.mcn.2010.12.005_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCRESAHA.108.180984","article-title":"RGS4 regulates parasympathetic signaling and heart rate control in the sinoatrial node","volume":"103","author":"Cifelli","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.mcn.2010.12.005_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","article-title":"Decreased expression of the GABAA receptor in fragile X syndrome","volume":"1121","author":"D'Hulst","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2010.12.005_bb0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2008.11.075","article-title":"Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor\/ataxia syndrome (FXTAS)","volume":"1253","author":"D'Hulst","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2010.12.005_bb0060","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biopsych.2008.10.026","article-title":"Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients","volume":"65","author":"Ding","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.mcn.2010.12.005_bb0065","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"Dolen","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10799890801941970","article-title":"GPCR-Kir channel signaling complexes: defining rules of engagement","volume":"28","author":"Doupnik","year":"2008","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.mcn.2010.12.005_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuron.2010.01.005","article-title":"Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132","volume":"65","author":"Edbauer","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2004.11.087","article-title":"Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse","volume":"377","author":"El Idrissi","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2010.12.005_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12311-008-0017-0","article-title":"The role of cerebellar genes in pathology of autism and schizophrenia","volume":"7","author":"Fatemi","year":"2008","journal-title":"Cerebellum"},{"key":"10.1016\/j.mcn.2010.12.005_bb0090","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1523\/JNEUROSCI.17-05-01539.1997","article-title":"Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes","volume":"17","author":"Feng","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0095","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1523\/JNEUROSCI.17-20-08024.1997","article-title":"Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain","volume":"17","author":"Gold","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0100","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1523\/JNEUROSCI.3697-08.2009","article-title":"The GABAB1a isoform mediates heterosynaptic depression at hippocampal mossy fiber synapses","volume":"29","author":"Guetg","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcn.2010.12.005_bb0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/CHI.0b013e318195bd15","article-title":"Physiological correlates of social avoidance behavior in children and adolescents with fragile X syndrome","volume":"48","author":"Hall","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.mcn.2010.12.005_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1073\/pnas.94.2.428","article-title":"RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha","volume":"94","author":"Hepler","year":"1997","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mcn.2010.12.005_bb0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1469-7610.2005.01556.x","article-title":"Social behavior and cortisol reactivity in children with fragile X syndrome","volume":"47","author":"Hessl","year":"2006","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.mcn.2010.12.005_bb0125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tins.2006.02.001","article-title":"The fragile X-cerebellum connection","volume":"29","author":"Huber","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0130","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/hmg\/ddn026","article-title":"Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice","volume":"17","author":"Jugloff","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2010.12.005_bb0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.neuron.2005.07.005","article-title":"Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in fragile X syndrome","volume":"47","author":"Koekkoek","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/191474a0","article-title":"Social dominance in inbred mouse strains","volume":"191","author":"Lindzey","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2010.12.005_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2009.02.066","article-title":"Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2010.12.005_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ajmg.1320300113","article-title":"Anthropometry in Martin\u2013Bell syndrome","volume":"30","author":"Loesch","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mcn.2010.12.005_bb0155","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1460-9568.2009.07073.x","article-title":"Repetitive behavior and increased activity in mice with Purkinje cell loss: a model for understanding the role of cerebellar pathology in autism","volume":"31","author":"Martin","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/0735-7044.122.2.293","article-title":"Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome","volume":"122","author":"McNaughton","year":"2008","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0896-6273(03)00034-5","article-title":"RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice","volume":"37","author":"Miyashiro","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0170","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1523\/JNEUROSCI.0937-07.2007","article-title":"Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome","volume":"27","author":"Muddashetty","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0175","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2008.07.031","article-title":"The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP","volume":"134","author":"Napoli","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2010.12.005_bb0180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1083\/jcb.200811058","article-title":"Translational control by RGS2","volume":"186","author":"Nguyen","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mcn.2010.12.005_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/bbrc.1997.7802","article-title":"Distribution of RGS4 mRNA in mouse brain shown by in situ hybridization","volume":"241","author":"Nomoto","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcn.2010.12.005_bb0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mol.109.056127","article-title":"Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures","volume":"76","author":"Pacey","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mcn.2010.12.005_bb0195","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.mp.4001562","article-title":"Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients","volume":"10","author":"Prasad","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.mcn.2010.12.005_bb0200","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/schbul\/sbp002","article-title":"RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample","volume":"36","author":"Prasad","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.mcn.2010.12.005_bb0205","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1073\/pnas.0504984102","article-title":"Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome","volume":"102","author":"Restivo","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mcn.2010.12.005_bb0210","first-page":"401","article-title":"Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ","volume":"96","author":"Riddle","year":"2005","journal-title":"Res"},{"key":"10.1016\/j.mcn.2010.12.005_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2210-9-9","article-title":"A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen","volume":"9","author":"Roof","year":"2009","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.mcn.2010.12.005_bb0220","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1523\/JNEUROSCI.18-03-00905.1998","article-title":"RGS4 inhibits signaling by group I metabotropic glutamate receptors","volume":"18","author":"Saugstad","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0225","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0896-6273(02)00768-7","article-title":"Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3","volume":"35","author":"Shahbazian","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0230","doi-asserted-by":"crossref","first-page":"24293","DOI":"10.1074\/jbc.M100089200","article-title":"Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation","volume":"276","author":"Shi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2010.12.005_bb0235","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/35059104","article-title":"RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III","volume":"409","author":"Sinnarajah","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2010.12.005_bb0240","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1601-183X.2005.00123.x","article-title":"Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome","volume":"4","author":"Spencer","year":"2005","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.mcn.2010.12.005_bb0245","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.09.023","article-title":"Rgs4 mRNA expression is decreased in the brain of Fmr1 knockout mouse","volume":"133","author":"Tervonen","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.mcn.2010.12.005_bb0250","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","article-title":"Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues","volume":"56","author":"Tzschentke","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mcn.2010.12.005_bb0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.mcn.2010.12.005_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00008877-200409000-00018","article-title":"Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex","volume":"15","author":"Ventura","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.mcn.2010.12.005_bb0265","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.04.014","article-title":"Differential compartmentalization and distinct functions of GABAB receptor variants","volume":"50","author":"Vigot","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0270","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1523\/JNEUROSCI.2266-07.2007","article-title":"Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation","volume":"27","author":"Volk","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuroscience.2009.04.033","article-title":"Insights into brain development from neurogenetic syndromes: evidence from fragile X syndrome, Williams syndrome, Turner syndrome and velocardiofacial syndrome","volume":"164","author":"Walter","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2010.12.005_bb0280","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","article-title":"FMRP acts as a key messenger for dopamine modulation in the forebrain","volume":"59","author":"Wang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2010.12.005_bb0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<248::AID-AJMG3>3.0.CO;2-1","article-title":"Synaptic synthesis of the fragile X protein: possible involvement in synapse maturation and elimination","volume":"83","author":"Weiler","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mcn.2010.12.005_bb0290","doi-asserted-by":"crossref","unstructured":"Westmark, C.J., Malter, J.S., 2007. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 5 (3), e53, 629\u2013639.","DOI":"10.1371\/journal.pbio.0050052"},{"key":"10.1016\/j.mcn.2010.12.005_bb0295","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1074\/jbc.272.18.11924","article-title":"RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis","volume":"272","author":"Yan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2010.12.005_bb0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1601-183X.2004.00087.x","article-title":"A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse","volume":"3","author":"Yan","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.mcn.2010.12.005_bb0305","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2010.12.005_bb0310","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nn1893","article-title":"A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability","volume":"10","author":"Zalfa","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mcn.2010.12.005_bb0315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2009.01.059","article-title":"Whole-brain expression analysis of FMRP in adult monkey and its relationship to cognitive deficits in fragile X syndrome","volume":"1264","author":"Zangenehpour","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2010.12.005_bb0320","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1124\/jpet.108.143990","article-title":"Inactivation of the maternal fragile X gene results in sensitization of GABAB receptor function in the offspring","volume":"327","author":"Zupan","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104474311000268X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104474311000268X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:23:29Z","timestamp":1559928209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104474311000268X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S104474311000268X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2010.12.005","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}